Trial Profile
Safety study of Trabectedin (ET-743) in patients with translocation-related sarcomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Adverse reactions
- Sponsors Taiho Pharmaceutical
- 10 Feb 2016 New trial record
- 01 Feb 2016 Results published in the European Journal of Cancer.